241 related articles for article (PubMed ID: 34079336)
1. Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell Lymphoma.
Chen H; He Y; Pan T; Zeng R; Li Y; Chen S; Li Y; Xiao L; Zhou H
Pharmgenomics Pers Med; 2021; 14():609-619. PubMed ID: 34079336
[TBL] [Abstract][Full Text] [Related]
2. Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes.
Pan T; He Y; Chen H; Pei J; Li Y; Zeng R; Xia J; Zuo Y; Qin L; Chen S; Xiao L; Zhou H
Front Oncol; 2021; 11():614211. PubMed ID: 33692952
[TBL] [Abstract][Full Text] [Related]
3. Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma.
Wu H; Zhang J; Fu L; Wu R; Gu Z; Yin C; He K
Technol Cancer Res Treat; 2023; 22():15330338221147772. PubMed ID: 36762399
[No Abstract] [Full Text] [Related]
4. Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma.
Li W; Yao R; Yu N; Zhang W
Cancer Biomark; 2024; 40(1):125-139. PubMed ID: 38517778
[TBL] [Abstract][Full Text] [Related]
5. A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma.
Xu H; Li Y; Jiang Y; Wang J; Sun H; Wu W; Lv Y; Liu S; Zhai Y; Tian L; Li L; Zhao Z
Front Genet; 2022; 13():827840. PubMed ID: 35774514
[No Abstract] [Full Text] [Related]
6. Identification of a novel model based on ferroptosis-related genes for predicting the prognosis of diffuse large B-cell lymphomas.
Wang J; Peng H; Zhang G; Yan W
Hematology; 2023 Dec; 28(1):2198862. PubMed ID: 37199349
[TBL] [Abstract][Full Text] [Related]
7. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M
Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma.
Li Y; Liu X; Chang Y; Fan B; Shangguan C; Chen H; Zhang L
Biomed Res Int; 2022; 2022():2645090. PubMed ID: 36281462
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma.
Zhang B; Zhang T; Zheng Z; Lin Z; Wang Q; Zheng D; Chen Z; Ma Y
Front Oncol; 2022; 12():1020566. PubMed ID: 36713586
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
12. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a risk scoring model for diffuse large B-cell lymphoma based on ferroptosis-related genes and its association with immune infiltration.
Xiong D; Li M; Zeng C
Transl Oncol; 2022 Feb; 16():101314. PubMed ID: 34920339
[TBL] [Abstract][Full Text] [Related]
14. Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma.
Pan M; Yang P; Wang F; Luo X; Li B; Ding Y; Lu H; Dong Y; Zhang W; Xiu B; Liang A
Front Genet; 2021; 12():648800. PubMed ID: 34178023
[TBL] [Abstract][Full Text] [Related]
15. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer.
Liu J; Ma H; Meng L; Liu X; Lv Z; Zhang Y; Wang J
Front Mol Biosci; 2021; 8():675651. PubMed ID: 34095228
[No Abstract] [Full Text] [Related]
16. Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma.
Wu W; Wang J; Jiang Y; Hu X; Tian Y; Chen L; Sun H; Li Y; Liu S; Lv Y; Guo J; Xu H; Xing D; Zhai Y; Tian L; Li C; He X; Luo K; Pan Y; Zhao Z
J Cancer; 2023; 14(3):403-416. PubMed ID: 36860924
[No Abstract] [Full Text] [Related]
17. An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy.
Hu J; Xu J; Yu M; Gao Y; Liu R; Zhou H; Zhang W
J Transl Med; 2020 Mar; 18(1):144. PubMed ID: 32228625
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.
Dai T; Li J; Lu X; Ye L; Yu H; Zhang L; Deng M; Zhu S; Liu W; Wang G; Yang Y
Pharmgenomics Pers Med; 2021; 14():927-945. PubMed ID: 34377010
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis-related genes are potential prognostic molecular markers for patients with colorectal cancer.
Liu Y; Guo F; Guo W; Wang Y; Song W; Fu T
Clin Exp Med; 2021 Aug; 21(3):467-477. PubMed ID: 33674956
[TBL] [Abstract][Full Text] [Related]
20. Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma.
Wen K; Yan Y; Shi J; Hu L; Wang W; Liao H; Li H; Zhu Y; Mao K; Xiao Z
Front Mol Biosci; 2021; 8():809672. PubMed ID: 34977159
[No Abstract] [Full Text] [Related]
[Next] [New Search]